Headache Clinical Trial
Official title:
Effectiveness of a Multimodal Prophylactic Strategy to Treat Post-dural Puncture Headache: A Retrospective Study
Neuraxial techniques are widely used in obstetric practice to provide analgesia and
anesthesia. A common complication associated with neuraxial anesthesia is post-dural puncture
headache (PDPH), resulting from unintentional or unintended puncture of the dura mater during
insertion of an epidural needle. Incidence of PDPH after spinal anesthesia is very low due to
the widespread use of non-cutting small diameter spinal needles. Incidence of "wet tap"
during epidural injection has been reported to be 1.5%, with 52-85% of these patients
developing PDPH.
When an obstetric patient develops PDPH, institution of an effective treatment is necessary.
Although PDPH tends to resolve spontaneously over a couple of weeks, it carries the risk of
potential complications. PDPH interfere with the ability of the mother to take care of her
baby, increases the risk of chronic headache and limits early ambulation, thereby increasing
the risk of venous thrombosis and pulmonary embolism. As important as treating PDPH when it
occurs is to prevent it when the dura is accidentally punctured during labor epidural
placement. Multiple therapeutic strategies have been reported in the medical literature to
prevent this outcome. Preventive measures range from conservative strategies to invasive
procedures. Bedrest and hydration have been traditionally recommended to try to prevent PDPH
when a wet tap occurs; however, no conclusive evidence supports their use. The use of oral
and intravenous caffeine is insufficiently supported by clinical evidence. Epidural morphine
and intravenous cosyntropin have been successfully used to prevent PDPH. Epidural injection
of normal saline reduces the gradient for CSF leak. The use of saline has shown variable
results in different studies. Although the results of some studies show insufficient evidence
about its effectiveness, administration of epidural saline is a technique relatively devoid
of significant adverse effects.
The institutional protocol recommends the combination of a multimodal approach to prevention
of PDPH after accidental dural puncture, based on strategies reported in the medical
literature. The protocol consists of the immediate administration of 60 cc of epidural normal
saline, followed by two preventive measures administered after delivery. After delivery, 1 mg
of intravenous cosyntropin and 3 mg of epidural morphine before catheter removal are
administered. This study tests the hypothesis that the multimodal prophylactic protocol
described above decreases the incidence of PDPH and the need to perform epidural blood patch,
compared to other strategies or no prophylactic management.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03472872 -
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
|
Phase 4 | |
Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
Withdrawn |
NCT02866084 -
Neuromodulation Treatment of Vestibular Migraines
|
N/A | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Not yet recruiting |
NCT04352218 -
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
|
Phase 2 | |
Completed |
NCT02734992 -
Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers
|
N/A | |
Completed |
NCT01327118 -
Prostaglandin F2alpha in a Human Headache Model
|
N/A | |
Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
Not yet recruiting |
NCT00969995 -
Identification of Inflammatory Markers in Migraine Patients
|
N/A | |
Not yet recruiting |
NCT00752921 -
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
|
Phase 4 | |
Terminated |
NCT00291395 -
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00212810 -
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
|
Phase 4 | |
Completed |
NCT00263094 -
An End to the Yom Kippur (and Ramadan) Headache
|
N/A | |
Completed |
NCT00135122 -
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
|
Phase 3 | |
Completed |
NCT02475005 -
An Intervention to Improve Adolescent Headache Self-management
|
N/A | |
Completed |
NCT03163901 -
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
|
N/A | |
Completed |
NCT01664585 -
Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life
|
N/A | |
Completed |
NCT04632420 -
Evaluation of Headache and Childbirth in a Chronic Pain Population
|
||
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|